BRIAN HOLLER / THE ARCHIVE
medical cannabis
Reporting, observations, and practical ideas from business, cannabis, media, culture, and the places they meet.
DEA Issues First Federal Registrations to Medical Cannabis Dispensaries
DEA has begun issuing federal registrations to qualifying medical cannabis dispensaries under the 2026 Schedule III framework, moving the policy into implementation while broader marijuana rescheduling remains unresolved.
Bedrocan Is Bankrupt and the Dutch Medical Monopoly Is Over
Bedrocan’s bankruptcy ended a long-running Dutch medical cannabis monopoly and exposed a broader lesson about protected markets: exclusivity can create stability, but it can also concentrate operational risk…
Topical CBD Cut Myofascial Pain 41% in a New Clinical Study
A controlled human study of topical CBD for myofascial pain reported a 41% reduction in pain, but the useful takeaway is precision: promising results should sharpen cannabis health…
The Fight Over Hemp CBD in Medicare
The hemp-derived CBD and Medicare fight sits at the intersection of evidence, federal benefit design and cannabis politics. The lawsuit can clarify policy questions, but it should not…
Congress Wants the VA to Study the Cannabis Veterans Actually Use
Veterans already use cannabis while federal research and guidance remain incomplete. The better policy response is research built around real-world products and behavior without outrunning what the evidence…
Doctors Are Finally Ready to Learn About Medical Cannabis. Operators Should Be Ready Too
Medical students increasingly want cannabis education while many report feeling unprepared to counsel patients. The opportunity is not for operators to replace clinicians—it is to support better evidence,…
A Minnesota Study Says Medical Cannabis Eased Anxiety and Depression in Autism Patients. Read the Fine Print.
Minnesota observational data from 1,800 medical-cannabis patients with autism found meaningful reported improvements in anxiety and other symptoms. Without a control group or standardized treatment, the findings are…
Congress Wants the VA to Finally Study Medical Marijuana for Veterans With PTSD and Chronic Pain
Congressional pressure for VA cannabis research reflects a persistent evidence gap around PTSD and chronic pain. Veteran access deserves rigorous study, transparent limitations and research designed around the…
Tennessee Just Dropped a 99 Page Medical Cannabis Proposal. Here Is What Operators Should Know
Tennessee’s 99-page medical-cannabis proposal is valuable before it becomes law because the details reveal the market policymakers are trying to build. Licensing, vertical integration, patient access and compliance…
Are Florida Medical Cannabis Operators Looking to Exit the $2 Billion Market?
Florida’s falling medical-cannabis license values show why headline market size and license economics are different things. Capital intensity, vertical integration and operating reality can erase scarcity value faster…
Balanced THC and CBD Cut Endometriosis Pain in Berlin Pilot Study
A Berlin pilot study of balanced THC/CBD for endometriosis pain reported promising improvements, but the sample was small and the evidence remains preliminary. Formulation details and study design…
Where Medical Cannabis Can Still Deliver Returns: A 12 Market Reality Check for 2026
A 12-market medical-cannabis survey shows why international opportunity cannot be reduced to population or headline legalization. Access, protectionism, GMP requirements and regulatory consistency determine whether growth becomes investable.
Cannabis Rescheduling Reality Check: DEA Has Given States Zero Implementation Guidance
Federal rescheduling can change legal classification faster than agencies can produce usable implementation guidance. States and businesses need plans for ambiguity, not just plans for the headline.
Some Guys Talking Ep. 12: Rachel Johnson — Powering Medical Cannabis with CMed
Rachel Johnson discusses CMed’s work around medical cannabis patient access and advocacy. The publisher’s description also explores education, policy, partnerships, hemp’s applications beyond THC, and the connections between…
The Cannabis Gene Pool Is Shrinking. That Is a Medical Problem and a Business Problem.
Research suggests commercial selection can narrow parts of cannabis genetic and chemical diversity. Preserving diverse, well-documented germplasm protects breeding options, research value, crop resilience and future product differentiation.
Eric Goepel Fought for Veterans the System Left Behind
Eric Goepel’s Veterans Cannabis Coalition work put a human face on the policy gap between veterans and cannabis access. A Connect in Cannabis archive conversation about advocacy, evidence,…
FIND YOUR NEXT THREAD